NDC 0310-3512 – Calquence
Acalabrutinib 100 mg/1 · Tablet, Film Coated · Oral
Product NDC0310-3512
Product details
- Brand name
- Calquence
- Generic name
- Acalabrutinib
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA216387
- Marketed since
- August 4, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Acalabrutinib 100 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0310-3512-60 | 60 TABLET, FILM COATED in 1 BOTTLE (0310-3512-60) | Aug 4, 2022 |
| 0310-3512-95 sample | 60 TABLET, FILM COATED in 1 BLISTER PACK (0310-3512-95) | Aug 4, 2022 |